0000899243-18-012922.txt : 20180515 0000899243-18-012922.hdr.sgml : 20180515 20180515180041 ACCESSION NUMBER: 0000899243-18-012922 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180511 FILED AS OF DATE: 20180515 DATE AS OF CHANGE: 20180515 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pearce David B. CENTRAL INDEX KEY: 0001679089 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24260 FILM NUMBER: 18838160 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY, SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMEDISYS INC CENTRAL INDEX KEY: 0000896262 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 113131700 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 BUSINESS PHONE: 2252922031 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 FORMER COMPANY: FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP DATE OF NAME CHANGE: 19940819 FORMER COMPANY: FORMER CONFORMED NAME: M&N CAPITAL CORP DATE OF NAME CHANGE: 19930125 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-05-11 0 0000896262 AMEDISYS INC AMED 0001679089 Pearce David B. 3854 AMERICAN WAY, SUITE A BATON ROUGE LA 70816 0 1 0 0 Chief Compliance Officer Common Stock 2018-05-11 4 S 0 984 71.55 D 15206 D Common Stock 2018-05-11 4 M 0 3659 52.61 A 18865 D Common Stock 2018-05-11 4 S 0 355 70.80 D 18510 D Common Stock 2018-05-11 4 S 0 3304 71.53 D 15206 D Common Stock 207 I Through 401(k) Plan Stock Option (Right to Buy) 52.61 2018-05-11 4 M 0 3659 0.00 D 2026-07-20 Common Stock 3659 10976 D The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.62 to $70.91, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.00 to $71.85, inclusive. The information in this report is based on a plan statement dated as of March 31, 2018. The Stock Options are subject to time-based vesting conditions. 3,659 Stock Options vested on July 20, 2017 and the remaining 10,976 Stock Options will vest in approximately equal installments on each of July 20, 2018, July 20, 2019 and July 20, 2020, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to pro-rated vesting provisions as provided in the award agreement for the Stock Options. /s/ Jennifer R. Guckert, pursuant to a power of attorney 2018-05-15